DTK: Filter, Intravascular, Cardiovascular

Product code DTK, “Filter, Intravascular, Cardiovascular” in FDA's classification database, is a Class II device type under 21 CFR 870.3375 (cardiovascular intravascular filter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 83 clearances under DTK, 31 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
DTK
Regulation
21 CFR 870.3375
Class
II
Panel
Cardiovascular
Clearances
83
Most recent
Sep 10, 2024
Third-party review
Not eligible
Implant
Yes

What it covers

A cardiovascular intravascular filter is an implant that is placed in the inferior vena cava for the purpose of preventing pulmonary thromboemboli (blood clots generated in the lower limbs and broken loose into the blood stream) from flowing into the right side of the heart and the pulmonary circulation.

The identification in 21 CFR 870.3375, cardiovascular intravascular filter. FDA gives DTK no definition of its own, so the regulation’s describes it.

FDA flags DTK devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K242612Option ELITE Vena Cava Filter System (352506070E 352506100E)Argon Medical Devices, Inc.Sep 10, 2024Special
K240578VenaTech® LP Vena Cava Filter System and VenaTech® Convertible Vena Cava Filter SystemB.Braun Medical, Inc.Jul 31, 2024Traditional
K241507ALN Optional Vena Cava Filter (FB.010500, FF.010995, FJ.120096, FB.HOOK, FF.HOOK, FJ.HOOK)Aln S.A.R.L.Jun 26, 2024Special
K240257Denali™ Vena Cava Filter System – Femoral and Jugular/Subclavian Delivery KitBdFeb 29, 2024Special
K233680Celect Platinum Vena Cava Filter Set for Femoral Vein Approach (IGTCFS-65-1-FEM-CELECT-PT); Celect Platinum Vena Cava Filter Set for Jugular Vein Approach (IGTCFS-65-1-JUG-CELECT-PT); Celect Platinum Vena Cava Filter Set for Femoral and Jugular Vein Approach (IGTCFS-65-1-UNI-CELECT-PT); Günther Tulip Vena Cava Filter Set for Femoral Vein Approach (IGTCFS-65-1-FEM-TULIP); Günther Tulip Vena Cava Filter Set for Jugular Vein Approach (IGTCFS-65-1-JUG-TULIP); Günther Tulip Vena Cava FilterWilliam Cook Europe ApsJan 18, 2024Traditional
K211875Cook Celect Platinum Vena Cava Filter Set for Femoral Vein Approach, Cook Celect Platinum Vena Cava Filte Set for Jugular Vein Approach, Cook Celect Platinum Vena Cava Filter Set for Femoral and Jugular Vein ApproachWilliam Cook Europe ApsJul 28, 2021Special
K211874Günther Tulip Vena Cava Filter Set for Femoral Vein Approach, Günther Tulip Vena Cava Filter Set for Jugular Vein Approach, Günther Tulip Vena Cava Filter Set for Femoral and Jugular Vein ApproachWilliam Cook Europe ApsJul 28, 2021Special
K181202Sentry IVC FilterNovate Medical , Ltd.Jun 6, 2018Special
K173236Sentry IVC FilterNovate Medical , Ltd.Feb 22, 2018Traditional
K172557Gunther Tulip Vena Cava Filter Set for Femoral Vein Approach, Gunther Tulip Vena Cava Filter Set for Jugular Vein Approach, Gunther Tulip Vena Cava Filter Set for Femoral and Jugular Vein ApproachWilliam Cook Europe ApsNov 20, 2017Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 83 with a free account)

Clearances by year

31 DTK 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2024529
2021241
2018285
2017588
2016384
2015299
2014230
2013391
20125156
20112207

Who submits

14 applicants cleared a DTK device since 2011. 61% of the clearances went to applicants in United States, then Denmark (19%), France (10%) and Ireland (10%). By type: Traditional 55%, Special 39% and Abbreviated 6%.

ApplicantClearances since 2011
William Cook Europe Aps9
C.R. Bard, Inc.5
Novate Medical , Ltd.3
Aln Implants Chirurgicaux2
Crux Biomedical2
Rex Medical, L.P.2
Aln S.A.R.L.1
Argon Medical Devices, Inc.1

How FDA classifies it

Class II. The special controls for this device are:

(1) “Use of International Standards Organization's ISO 10993 ‘Biological Evaluation of Medical Devices Part I: Evaluation and Testing,’ ” and

(2) FDA's:

(i) “510(k) Sterility Review Guidance and Revision of 2/12/90 (K90-1)” and

(ii) “Guidance for Cardiovascular Intravascular Filter 510(k) Submissions.”

From 21 CFR 870.3375. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.3375 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DTK clearances declared.

Ask about DTK

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about DTK

What is FDA product code DTK?

Product code DTK, “Filter, Intravascular, Cardiovascular” in FDA's classification database, is a Class II device type under 21 CFR 870.3375 (cardiovascular intravascular filter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 83 clearances under DTK, 31 of them since 2011.

How many 510(k) clearances are there under DTK?

FDA’s 510(k) database listed 83 clearances under DTK as of Oct 29, 2026, 31 of them decided since 2011; the most recent decision was Sep 10, 2024. The Predicate Finder searches the live database.

Which companies have the most DTK clearances?

Since 2011: William Cook Europe Aps (9), C.R. Bard, Inc. (5), Novate Medical , Ltd. (3), Aln Implants Chirurgicaux (2) and Crux Biomedical (2). 14 applicants have cleared a DTK device in that time.

Sources

  1. FDA product classification: DTK · Product Classification database
  2. 21 CFR 870.3375: Cardiovascular intravascular filter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for DTK · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow DTKGet an email when FDA clears, recalls or publishes guidance for DTK devices.

Know what FDA already cleared.